SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-18-012517
Filing Date
2018-10-26
Accepted
2018-10-26 17:01:11
Documents
20
Period of Report
2018-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp97437_6k.htm 6-K 15699
2 EXHIBIT 99.1 dp97437_ex9901.htm EX-99.1 26404
3 GRAPHIC image_001.jpg GRAPHIC 355521
4 GRAPHIC image_002.jpg GRAPHIC 541735
5 GRAPHIC image_003.jpg GRAPHIC 237179
6 GRAPHIC image_004.jpg GRAPHIC 324026
7 GRAPHIC image_005.jpg GRAPHIC 435555
8 GRAPHIC image_006.jpg GRAPHIC 463103
9 GRAPHIC image_007.jpg GRAPHIC 301537
10 GRAPHIC image_008.jpg GRAPHIC 354506
11 GRAPHIC image_009.jpg GRAPHIC 391912
12 GRAPHIC image_010.jpg GRAPHIC 319478
13 GRAPHIC image_011.jpg GRAPHIC 444606
14 GRAPHIC image_012.jpg GRAPHIC 439828
15 GRAPHIC image_013.jpg GRAPHIC 392953
16 GRAPHIC image_014.jpg GRAPHIC 352200
17 GRAPHIC image_015.jpg GRAPHIC 490377
18 GRAPHIC image_016.jpg GRAPHIC 594330
19 GRAPHIC image_017.jpg GRAPHIC 379814
20 GRAPHIC image_018.jpg GRAPHIC 384710
  Complete submission text file 0000950103-18-012517.txt   9965098
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 181142206
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences